Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -133,480 | -29,440 | -296,480 | -251,450 | -96,420 |
| Depreciation Amortization | 46,770 | 23,620 | 102,840 | 77,690 | 52,240 |
| Other Working Capital | -30,920 | -17,360 | -20,400 | 13,690 | 26,420 |
| Other Operating Activity | 84,170 | 6,540 | 137,190 | 116,730 | 6,670 |
| Operating Cash Flow | $-33,460 | $-16,640 | $-76,850 | $-43,340 | $-11,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,280 | -1,290 | -31,590 | -28,050 | -21,750 |
| Net Acquisitions | 0 | 0 | -23,500 | -35,900 | -35,900 |
| Other Investing Activity | -31,080 | -41,900 | 105,690 | 74,200 | 34,980 |
| Investing Cash Flow | $-33,360 | $-43,190 | $50,600 | $10,250 | $-22,670 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 62,820 | 59,530 | 3,610 | 3,720 | 6,780 |
| Financing Cash Flow | $62,820 | $59,530 | $3,610 | $3,720 | $6,780 |
| Exchange Rate Effect | 20 | -80 | -720 | -830 | -360 |
| Beginning Cash Position | 18,510 | 18,510 | 41,870 | 41,870 | 41,870 |
| End Cash Position | 14,530 | 18,120 | 18,510 | 11,670 | 14,520 |
| Net Cash Flow | $-3,980 | $-390 | $-23,360 | $-30,200 | $-27,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,460 | -16,640 | -76,850 | -43,340 | -11,090 |
| Free Cash Flow | -33,460 | -16,640 | -76,850 | -43,340 | -11,090 |